1 Ajoene is a garlic compound with anti-platelet properties and, in addition, was shown to inhibit cholesterol biosynthesis by aecting 3-hydroxy-3-methyl-glutaryl coenzyme A (HMG-CoA) reductase and late enzymatic steps of the mevalonate (MVA) pathway. 2 MVA constitutes the precursor not only of cholesterol, but also of a number of non-sterol isoprenoids, such as farnesyl and geranylgeranyl groups. Covalent attachment of these MVA-derived isoprenoid groups (prenylation) is a required function of several proteins that regulate cell proliferation. We investigated the eect of ajoene on rat aortic smooth muscle cell proliferation as related to protein prenylation. 3 Cell counting, DNA synthesis, and cell cycle analysis showed that ajoene (1 ± 50 mM) interfered with the progression of the G1 phase of the cell cycle, and inhibited rat SMC proliferation. 4 Similar to the HMG-CoA reductase inhibitor simvastatin, ajoene inhibited cholesterol biosynthesis. However, in contrast to simvastatin, the antiproliferative eect of ajoene was not prevented by the addition of MVA, farnesol (FOH), and geranylgeraniol (GGOH). Labelling of smooth muscle cell cellular proteins with [3H]-FOH and [3H]-GGOH was signi®cantly inhibited by ajoene. 5 In vitro assays for protein farnesyltransferase (PFTase) and protein geranylgeranyltransferase type I (PGGTase-I) con®rmed that ajoene inhibits protein prenylation. High performance liquid chromatography (HPLC) and mass spectrometry analyses also demonstrated that ajoene causes a covalent modi®cation of the cysteine SH group of a peptide substrate for protein PGGTase-I. 6 Altogether, our results provide evidence that ajoene interferes with the protein prenylation reaction, an eect that may contribute to its inhibition of SMC proliferation.
Introduction
Garlic (Allium sativum) has been advocated as a remedy for the treatment and prevention of a number of diseases, including atherosclerosis and cancer. However, several clinical studies conducted during the last three decades have shown contradictory lipid-lowering activity and bene®cial eects on cancer incidence (Agarwal, 1996; Buiatti et al., 1989; You et al., 1989) . Therapeutic actions of garlic, although still discussed, have been attributed primarily to its organosulphuric compounds, but more detailed studies on chemically de®ned garlic components are needed to better clarify its pharmacological properties (Agarwal, 1996) . In vitro and in vivo studies have been conducted to evaluate the antiproliferative activity of garlic and its constituents. For instance, garlic extracts prepared from 1% alcoholic extraction of garlic powder, containing a mixture of organosulphur compounds, was found to inhibit [3H]-thymidine incorporation in cultured trophoblasts and endothelial cells (Sooranna et al., 1997) . Further, development of spontaneous mammary tumours in C3H mice has been shown to be inhibited by feeding fresh garlic which contains active allinase (Kroning. 1964) . Allinase acts on alliin to produce allicin, the precursor for several organosulphuric compounds including ajoene. Therefore, allicin and/or its metabolites, rather than alliin may exert the chemopreventive action of garlic (Kroning. 1964) .
Ajoene ( Figure 1 ) is a well-established antiplatelet agent, and its inhibitory eect on platelet aggregation has been extensively studied and documented both by in vivo and in vitro experiments (Apitz-Castro et al., 1986a, b; 1988; . Further, ajoene is a potent modulator of membranedependent functions of immune cells, that are under control of the signal-transduction system (Romano et al., 1997) . Beyond this action, recent evidence showed that ajoene inhibits proliferation and induces apoptosis of several cancer cell lines, which ultimately leads to the reduction of tumour growth in vivo (Li et al., 2002) . Allicin and ajoene were also reported to signi®cantly decrease cholesterol biosynthesis in rat hepatocytes and HepG2 cells by inhibiting HMG-CoA reductase and late steps of the MVA pathway which leads to the accumulation of the precursor lanosterol (Dirsch et al., 1998; Gebhardt et al., 1994; Urbina et al., 1993) . Mevalonate (MVA) is the precursor not only for cholesterol but also for a number of non-sterol isoprenoids, such as the farnesyl and geranylgeranyl groups, which become covalently attached to proteins that are essential for cell proliferation (Glomset et al., 1990; Goldstein & Brown, 1990; Grunler et al., 1994) . Indeed, protein prenylation is required for membrane association and therefore function of several proteins involved in the regulation of cell proliferation, including p21 ras (Grunler et al., 1994) .
Thus, given the evidence for the requirement of MVAderived isoprenoids for cell growth, and for the ability of ajoene to interfere with the MVA pathway (Gebhardt et al., 1994) , our study was undertaken to evaluate the eect of ajoene on SMCs proliferation as related to protein prenylation. Our results show that ajoene inhibits SMCs proliferation by interfering with the progression of the G1 phase of the cell cycle. In addition, at similar concentrations, we observed an inhibition of cholesterol biosynthesis and a decrease in the incorporation of [3H]-FOH and [3H]-GGOH into cellular proteins. In vitro assays for PFTase and PGGTase-I activities con®rmed the ability of ajoene to inhibit protein prenylation. By reverse phase high performance liquid chromatography (HPLC) and mass spectrometry analyses, we determined the mechanism of inhibition of protein prenylation.
Methods

Materials
Eagle's minimum essential medium (MEM), trypsin ethylendiaminetetraacetate, penicillin (10,000 U ml 71 ), streptomycin (10 mg ml 71 ), tricine buer (1 M, pH 7.4) and non-essential amino acid solution (1006) were purchased from Gibco, and FCS was from Mascia Brunelli. Disposable culture¯asks and petri dishes were from Corning Glassworks, and ®lters were from Millipore. ) and molecular weight protein standards were from Amersham. Isoton II was purchased from Instrumentation Laboratories. All-trans FOH, was purchased from Sigma, and all-trans geranyl-geraniol (GGOH) was kindly provided by Prodotti Roche. SDS, TEMED, ammonium persulphate, glycine, acrylamide solution (30% T, 2.6% C) were obtained from Bio-Rad Laboratories. All-trans FOH [1- ) were from American Radiolabeled Chemicals. Avidin-agarose was from Pierce. Cytox Dye was purchased from Molecular Probes. Ajoene (Figure 1) , was obtained as previously described (Apitz-Castro et al., 1983) , and dissolved in ethanol; control cells received the same volume of the solvent (0.5% ®nal concentration). Simvastatin in its lactone form (Merck, Sharp & Dohme Research Laboratories) was dissolved in 0.1 M NaOH to give the active form, and the pH was adjusted to 7.4 by adding 0.1 M HCl. The solution was sterilized by ®ltration.
Cell proliferation and DNA synthesis
Smooth muscle cells (SMC) were cultured from the intimalmedial layers of aorta of male Sprague ± Dawley rats as previously described (Corsini et al., 1995) .
Cell proliferation was evaluated by cell counting with a Coulter Counter model ZM (Coulter Instruments) after trypsinization of the monolayers (Corsini et al., 1993) , and DNA synthesis was estimated by nuclear incorporation of [ 3 H]-thymidine (Corsini et al., 1995) .
Cell cycle analyses
Flow cytometry was utilized to analyse cell cycle distribution. Cells were trypsinized and centrifuged for 5 min at 1000 r.p.m. Pellets were resuspended in 0.5 ml of permeabilizing buer (0.5 mM in 100 mM Tris pH 7.4, 150 mM NaCl, 1 mM CaCl 2 , 0.5 mM MgCl 2 0.1% NP-40) containing Cytox Dye (®nal concentration 0.5 mM). Samples were placed in the dark for 30 min and the green¯uorescence of individual nuclei was measured. Nuclear Cytox Dye¯uorescence signal was recorded on the FL1 channel of a FACS scan¯ow cytometer (Becton Dickinson) and analysed with CellQuest software. The number of cells in G 0 /G 1 , S and G 2 /M phases was expressed as percentages of total events (10,000 cells).
Synthesis of total sterols
The synthesis of cholesterol was determined by measuring the incorporation of radioactive acetate into cellular sterols (Corsini et al., 1995 (Corsini et al., 1999; Ferri et al., 2001) . After this time, cell monolayers were scraped into 1.5 ml of phosphate buered saline (PBS) containing 1 mM phenylmethylsulphonyl¯uoride, and the resuspended cells collected and centrifuged (14,000 r.p.m. 63 min.). Cells pellets were delipidated with cold acetone and two extractions with chloroform/methanol (2 : 1). The delipidated proteins were solubilized in 3% SDS, 62.5 mM Tris-HCl, pH 6.8, and an aliquot (40 mg protein) was analysed by 12.5% SDS ± PAGE (Corsini et al., 1999; Ferri et al., 2001) . The gel was treated with Amplify (Amersham) and exposed to Kodak X-Omat-AR ®lm at 7708C for 2 ± 4 weeks. Fluorographic signals were analysed by densitometric scanning. 
Assays for inhibition of PFT and PGGT-I by ajoene
Recombinant rat PFTase and PGGTase-I were expressed in the Sf9/baculovirus system and puri®ed as described (Yokoyama et al., 1997) . The standard reaction mixture for PFTase assay contains 0.75 mM (0.3 mCi) [ 3 H]-FPP and 5 mM RAS-CVIM in a total volume of 20 ml containing 30 mM potassium phosphate, 0.5 mM MgCl 2 , 20 mM ZnCl 2 , pH 7.7. PGGTase-I assay was carried out using 0.75 mM (0.3 mCi) [ 3 H]-GGPP and 5 mM H-Ras-CVLL as substrates. Stock solutions of ajoene were prepared in absolute ethanol, and a 1 ml aliquot was added to the reaction mixture (®nal concentration of ethanol is 5%). Reactions were initiated by adding rat PFTase or PGGTase-I (20 ng). After incubation at 308C for 20 min, the reaction was terminated by adding 200 ml of 10% HCl in ethanol. The amount of the prenylated protein product was quanti®ed by the glass ®bre-®lter method as described previously (Pompliano et al., 1992) . In some cases, 50 mM biotinylated peptide substrates, biotin-lamine B peptide (biotin-GTPRASNRSCAIS) and biotin-g6 peptide (biotin-NPFREKKFFCAIL) were used as substrates of PFT and PGGT-I, respectively. The amount of radioactivity transferred to the peptides was determined by the method using avidinagarose as described (Yokoyama et al., 1991) .
Analyses of products from incubation of ajoene and biotin-g6 peptide by reverse-phase HPLC and mass spectrometry Ajoene (50 mM) and biotin-g6 peptide (25 mM) were incubated at 308C for 30 min in a total volume of 200 ml containing 30 mM potassium phosphate, pH 7.7, 1 mM MgCl 2 , 20 mM ZnCl 2 . The sample was subjected to HPLC on a C18 reversephase column (Vydac 218TP52, 4.66250 mm). The column was developed at a¯ow rate of 1 ml min with a solvent gradient using 0.06% tri¯uoroacetic acid in water (solvent A) and 0.054% tri¯uoroacetic acid in acetonittrile (solvent B): 20 ± 80% B over 60 min. The absorbance at 218 nm was monitored.
For mass spectrometry analyses, a mixture of ajoene (500 mM) and biotin-g6 peptide (25 mM) was incubated at 308C for 30 min in a 200 ml mixture without buer or salt, and an aliquot was infused into the electrospray mass spectrometer (Bruker/Hewlett-Packard Esguire).
Statistical analyses
Experimental data are expressed as mean+s.d. The eects of the tested compounds versus control on the dierent parameters were analysed by a one-way ANOVA followed by Bonferroni test. The concentration of compounds required to inhibit 50% of cell proliferation, [ 3 H]-thymidine incorporation and cholesterol biosynthesis (IC 50 ) was calculated by linear regression analyses of the logarithm of the concentration (in micromoles per litre) versus logit.
Results
Effect of ajoene on arterial SMC proliferation and cell cycle progression
The antiproliferative action of ajoene was studied in rat aortic SMCs at concentrations ranging from 1 to 50 mM. In the ®rst set of experiments, cell proliferation was measured after 3 days of growth in the presence of increasing concentrations of ajoene. Ajoene decreased SMC proliferation in a concentration-dependent manner with an IC 50 -value of 5.7 mM (Figure 2A ). In addition, ajoene inhibited [ 3 H]-thymidine incorporation in a concentration dependent manner (IC 50 =25.2 mM)( Figure 2B ). Similar potency of the antiproliferative eect of ajoene was observed on three dierent strains of rat SMC (data not shown).
To further investigate the antiproliferative eect of ajoene, we performed cell cycle analyses by¯owcytometry. Incubation of SMCs for 120 h with culture media containing 0.4% FCS led to the accumulation of the cells in the G1 phase (95.8%) with only a small percentage in the S phase (0.62%) ( Figure 3) . As expected, 20 h after stimulation with 10% FCS, the cells in S phase were increased to 5.8%, and those in G1 phase were decreased to 83.9% (Figure 3) . Incubation of SMCs with ajoene led to the accumulation of cells in the G1 phase in a concentration dependent manner, with a complete inhibition at 25 mM concentration (Figure 3) . Importantly, we did not detect any signi®cant increase in the percentage of sub G0/G1 cells even after incubation with 25 mM ajoene, which indicates a speci®c interference with the progression of the G1 phase of the cell cycle without induction of apoptosis ( Figure 3 ).
Effect of ajoene on the mevalonate pathway
It has previously been shown that ajoene inhibits cholesterol biosynthesis by interfering with dierent steps of the MVA pathway (Gebhardt et al., 1994) . To study whether ajoene inhibits SMCs proliferation by aecting one of the steps of the MVA pathway, we evaluated the eect of this compound versus the HMG-CoA reductase inhibitor simvastatin. We Figure 4 , ajoene strongly inhibited cholesterol biosynthesis with an IC 50 of 1.5 mM, and at similar concentrations, it also inhibited SMCs proliferation. Under the same experimental conditions, at least 80% inhibition of cholesterol biosynthesis was necessary to induce a decrease in SMC proliferation by simvastatin (Figure 4 ) (Corsini et al., 1993) . These results suggest a dierent antiproliferative's mechanism by the two compounds.
We have previously shown that MVA, FOH, and GGOH, counteract the antiproliferative eect on SMCs elicited by HMG-CoA reductase inhibitors (statins) but not by the protein prenylation inhibitor perillic acid (Corsini et al., 1995; Ferri et al., 2001; Raiteri et al., 1997) . As shown in Figure 5 , the antiproliferative eect of ajoene was not prevented by the addition of MVA, FOH and GGOH, suggesting that its action was directly related to the inhibition of protein prenylation.
To study whether ajoene interferes with protein prenylation, the incorporation of [ ]-GGOH were readily incorporated into speci®c proteins with molecular weights ranging from 21 to 72 kDa, as reported in previous studies (Corsini et al., 1999; Danesi et al., 1995;  Figure 3 Eect of ajoene on the cell cycle of rat aortic SMCs. Experimental conditions are as in Figure 1B . Flow cytometry analysis of the cell cycle was performed in the presence of 0.4%, and 10% FCS alone, or in the presence of the indicated concentrations of ajoene as described in`Methods'. FL-1: green¯uorescence. The data shown are representative of two independent experiments. (Figure 6 ). These data suggest that ajoene might exert its antiproliferative eect by interfering with protein prenylation process.
Inhibition of PFTase and PGGTas-I activity by ajoene in vitro
To further investigate the eect of ajoene on protein prenylation, we measured the activity of PFTase and PGGTase-I using Ras-CVIM and H-Ras-CVLL as substrates, respectively, in the absence of DTT. Ajoene inhibited PFTase and PGGTase I reactions in a dose-dependent manner with IC 50 values of 13.0 and 6.9 mM, respectively ( Figure 7A ). In the presence of 100 mM ajoene, which causes nearly complete inhibition of both reactions, increasing concentrations of DTT prevented the eect of ajoene, and led to even higher activity than that observed in the absence of both ajoene and DTT ( Figure 7B ). Similar inhibitory eects of ajoene were also observed when PFTase and PGGTase-I assays were carried out with peptide substrates biotin-lamine B peptide (biotin-GTPRASNRSCAIS) and biotin-g6 peptide (biotin-NPFREKKFFCAIL) (data not shown).
Ajoene contains a disulphide bond that is reductively cleavable by DTT (Figure 1) . Thus, our results suggest that the disul®de linkage in ajoene is an indispensable element for the ability of the compound to inhibit PFTase and PGGTase-I reactions.
HPLC and mass spectrometry analyses of the product(s) from incubation of ajoene and biotin-g6 peptide
We next studied whether ajoene inhibits the prenylation reaction by modi®cation of the cysteine SH group of the PGGTase-I substrate (biotin-NPFREKKFFCAIL). When a mixture of ajoene and biotin-g6 peptide was incubated and subjected to reverse-phase HPLC analyses, we observed the formation of a new compound (retention time, 22.3 min) that separated from ajoene (20.1 min) and the peptide (19.1 min) ( Figure 8A,B,C) . This compound was completely removed from the mixture by treatment with avidin-agarose prior to HPLC analyses ( Figure 8D ) and was ninhydrin-test positive, indicating that the compound is a biotinylated peptide with modi®cation by ajoene.
Biotin-g6 peptide contains two lysine and one arginine residues. Electron spray mass spectrometry of this peptide (molecular mass=1952.4) gave a major ion signal of 651.6 that corresponds to a triply charged ion ([M+3H]/3z) of the peptide. The mass spectrum of a mixture of biotin-g6 and ajoene showed major ion signals of 675.7, 651.6, and 781.5 , or a mixture of ajoene (50 mM) and biotin g6 peptide (25 mM) (panel C), was incubated at 308C for 30 min and subjected to C18 reverse-phase HPLC as described in`Methods'. An identical mixture as panel C was also chromatographed after removal of biotinylated compounds with 100 ml of avidin-agarose gel (panel D). The elution was carried out by a gradient of acetonitrile concentrations from 20 to 80% over 60 min.
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Ajoene cell growth protein prenylation N. Ferri et al( Figure 9A ). The 651.6 signal corresponds to the triply charged peptide, and the 781.5 signal corresponds to an ion of dimerized peptide ([2M+5H]/5z) linked via a disulphide bridge since this signal disappeared when incubated with DTT ( Figure 9B ). The 675.7 signal is a triply charged ion of a compound with molecular mass of 2041.1, which is 71.7 mass unit larger than that of biotin-g6 peptide and corresponds to the peptide covalently modi®ed with CH 2 =CHCH 2 -S-, a portion of ajoene. The 675.7 signal was greatly reduced by further incubation with 50 mM DTT ( Figure 9B) , showing that this compound is the peptide attached via a disulphide to CH 2 =CHCH 2 -S-. The minor mass signal of 705 formed in the mixture ( Figure 9A ) may be a triply charged ion of a compound with molecular mass of 2112 that is 159.6 unit larger than the peptide, suggesting that the peptide may also be modi®ed with the larger portion of ajoene CH 2 =CHCH 2 S(O)CH 2 CH=CH-S-, but with about 4 fold less eciency compared to modi®cation with CH 2 =CHCH 2 -S-. These results suggest that the cysteine SH group of the peptide is modi®ed with the fragments (preferentially with the smaller one CH 2 =CHCH 2 -S-) of ajoene by disulphide bond. Preferential labelling of the peptide with the 3-carbon portion of ajoene is expected, as the vinyl thiolate fragment is a better leaving group than is the allylic thiolate. This blockage of the SH group(s) of protein prenyltransferase substrates may be the mechanism by which ajoene inhibits prenyl modi®cation of proteins in SMCs.
Discussion and conclusion
In the present study we have evaluated the eect of synthetic ajoene, an organosulphur compound derived from garlic, on SMCs proliferation as related to protein prenylation. Incubation of SMCs with ajoene showed a dose dependent inhibition of cell proliferation and thymidine incorporation (Figure 2A and B) . Cell cycle analysis also demonstrated that ajoene speci®cally blocks the cell cycle in G1 phase, leading to the accumulation of the cells in the G0/G1 (Figure 3) .
The inhibitory eects on the G1 phase observed in cells treated with HMG-CoA reductase inhibitors (Jakobisiak et al., 1991) , with PFTase inhibitors (Sepp-Lorenzino & Rosen, 1998) , with PGGTase I inhibitors (Stark et al., 1998) , and with a dual PFTase and PGGTases inhibitor (Ferri et al., 2001) , suggest the involvement of speci®c isoprenoids metabolites in the regulation of the G1/S phase transition of the cell cycle. The addition of MVA, all-trans FOH and all-trans GGOH, precursors of prenylated proteins, restored cell proliferation inhibited by HMG-CoA reductase inhibitors (statins) ( Figure 5B ) (Corsini et al., 1993) , but not by the protein prenylation inhibitor perillic acid (Ferri et al., 2001) , further con®rming a speci®c role of isoprenoids in regulating cell proliferation (Raiteri et al., 1997) . Similar to perillic acid, MVA or its isoprenoids derivatives (FOH or GGOH) did not counteract ajoene-induced blockade of SMC proliferation ( Figure 5A ). These results suggest that ajoene might inhibit protein prenylation. In fact, analysis of the incorporation of radiolabelled all-trans FOH and all-trans GGOH into cellular proteins, demonstrated that ajoene reduces the incorporation of both prenols, with a more marked eect on [ 3 H]-GGOH. However, in contrast to perillic acid, ajoene not only aects protein prenylation, but also exerted a strong inhibition of cholesterol biosynthesis. Nevertheless, because ajoene's eect on SMC proliferation was not counteracted by MVA and its isoprenoids derivatives, and in contrast to simvastatin, was observed at concentrations similar to those required for inhibiting cholesterol biosynthesis, ajoene's action is more likely due to a decrease in protein prenylation than a decrease of HMG-CoA reductase activity (Gebhardt et al., 1994) .
To date, three classes of enzymes, protein farnesyltransferase (PFTase) and protein geranylgeranyltransferases (PGGTase I and II) have been identi®ed in mammals to catalyse the transfer of prenyl groups to the sulphur atom of the cysteine residue located at fourth amino acid from the carboxyl terminus of the proteins (CAAX domain; where the C is a cysteine, the two A residues are aliphatic amino acids, and the X can be methionine, serine, alanine, glutamine or leucine) (Casey & Seabra, 1996) . We used an in vitro assay to further investigate the eect of ajoene on protein prenylation, and showed a signi®cant inhibition of both PFTase and PGGTase-I activity by ajoene. Interestingly, the concentrations required for inhibiting SMC proliferation, PFTase, and PGGTase-I activities are similar (IC50=5.7, 6.9, and 13.0 mM respectively). Furthermore, a signi®cant reduction of the incorporation of [ Ajoene cell growth protein prenylation N. Ferri et al was observed in the presence of 10 ± 25 mM ajoene. These data illustrate a correlation between the eect of ajoene on cell proliferation and protein prenylation.
The fact that the inhibitory eects of ajoene on PFTase and PGGTase-I activity were blocked by DTT ( Figure 7B ) suggests the possibility that ajoene modi®es the substrate at the SH group of cysteine. Accordingly, HPLC and mass spectrometry analyses, showed the formation of adducts between the cysteine SH group of the CAAX peptide (bioting6) and fragments of ajoene. These results led us to postulate that ajoene might interfere with protein prenylation by a covalent modi®cation of the cysteine residue of protein substrates without a speci®c inhibitory eect on PFTase and/or PGGTase-I. The more marked inhibitory eect of ajoene on [ 3 H]-GGOH versus [ 3 H]-FOH incorporation into cellular proteins could be due to dierences in the intracellular pool sizes of farnesyl pyrophosphate (FPP), and geranylgeranyl pyrophosphate (GGPP) (Corsini et al., 1999) .
Although this is the ®rst report showing the eect of ajoene on protein prenylation, our study is in agreement with the evidence that ajoene inhibits the activity of protein tyrosine phosphatases in platelets, which is a class of molecules that undergo farnesylation (Cates et al., 1996; Villar et al., 1997) . It is noteworthy to mention that organosulphuric compounds derived from garlic, containing the disulphide moiety, or an active thioallyl group, have been shown to react in vitro and in vivo with cysteine to form S-allyl mercaptocysteine adducts (Weisberger & Pensky, 1958) . It has also been shown that ajoene alters glutathione metabolism, (Scharfenberg et al., 1994) , and that removal of the sulphide group of ajoene induces a 2 fold decrease in its ability to suppress collageninduced platelet aggregation (Block et al., 1986) .
Although the antiproliferative eects of ajoene have received little attention, a recent study shows that Z-ajoene is able to inhibit HL60 cells proliferation and tumour growth in vivo. The eect seems to be due to a speci®c inhibition of micotubules formation mediated by ajoene, and therefore a blockage of the transition of the G2/M phase of the cell cycle (Li et al., 2002) . Although it is possible that multiple mechanisms of action can contribute to the antiproliferative eect of ajoene, the discrepancy between our results and the above study can potentially be explained by a speci®c eect of Z-ajoene versus a mixture of the isomers utilized in our study, or by the dierent cell type investigated. It is also important to note that, although ajoene can induce apoptosis in the human promyelcytic leukemia cell line HL-60, we did not observed hypodiploid cells in SMCs (Dirsch et al., 1998; Li et al., 2002) . Dierent susceptibility of the cells to undergo apoptosis can account for the discrepancy between these observations, since ajoene does not induce apoptosis in peripheral blood mononuclear cells isolated from healthy humans (Dirsch et al., 1998) .
In conclusion we show that ajoene, a synthetic garlic component, inhibits protein prenylation and SMCs proliferation. We demonstrate that ajoene, by covalent reaction, leads to covalent modi®cation of the cysteine SH group of the CAAX motif of protein prenyl group acceptors, an eect which may contributes to the ability of ajoene to inhibit SMC proliferation.
